247 related articles for article (PubMed ID: 8909484)
1. Measles vaccination during the respiratory virus season and risk of vaccine failure.
Edmonson MB; Davis JP; Hopfensperger DJ; Berg JL; Payton LA
Pediatrics; 1996 Nov; 98(5):905-10. PubMed ID: 8909484
[TBL] [Abstract][Full Text] [Related]
2. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
Yuan L
CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
[TBL] [Abstract][Full Text] [Related]
3. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
McDonnell LF; Jorm LR; Patel MS
Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
[TBL] [Abstract][Full Text] [Related]
4. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
5. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
6. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for measles vaccine failure among immunized students.
Hull HF; Montes JM; Hays PC; Lucero RL
Pediatrics; 1985 Oct; 76(4):518-23. PubMed ID: 4047794
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of measles in a highly vaccinated secondary school population.
Sutcliffe PA; Rea E
CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
[TBL] [Abstract][Full Text] [Related]
9. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study.
Kabir Z; Long J; Reddaiah VP; Kevany J; Kapoor SK
Bull World Health Organ; 2003; 81(4):244-50. PubMed ID: 12764490
[TBL] [Abstract][Full Text] [Related]
10. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
Egami T; Egami K; Tanoue A
Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study.
Garly ML; Jensen H; Martins CL; Balé C; Baldé MA; Lisse IM; Aaby P
Pediatr Infect Dis J; 2004 Dec; 23(12):1086-92. PubMed ID: 15626943
[TBL] [Abstract][Full Text] [Related]
12. Appropriate age for measles vaccination in the United States.
Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
14. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
Lin M
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
[TBL] [Abstract][Full Text] [Related]
15. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
Mahomva AI; Moyo IM; Mbengeranwa LO
Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
[TBL] [Abstract][Full Text] [Related]
18. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
[TBL] [Abstract][Full Text] [Related]
19. Protection after two doses of measles vaccine is independent of interval between doses.
De Serres G; Sciberras J; Naus M; Boulianne N; Duval B; Rochette L
J Infect Dis; 1999 Jul; 180(1):187-90. PubMed ID: 10353877
[TBL] [Abstract][Full Text] [Related]
20. A case control study to assess the efficacy of measles vaccine.
Rajapaksa L
Ceylon Med J; 1993 Dec; 38(4):178-80. PubMed ID: 8143333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
